We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cobra Bio-Man. | CBF | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.25 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.25 | 2.25 |
| Top Posts |
|---|
Posted at 22/2/2010 17:04 by skylift the_doctorthanks for the advice As I do not need the cash now, I will wait and see what happens. Ironically, I would expect the new company to do very well with their connections and potentially large synergistic cost savings Who will benefit? The old management but certainly not investors |
Posted at 22/2/2010 13:52 by skylift the_doctorI am looking at the picture now, not then and IMO there is much greater value now - the order book should still be there, for example. The Dixons had no alternative to accept as private investors with such a large stake; also, the directors 'recommend' the offer when they manage to keep their jobs and also have no significant holding, coincidentally - I also do not want to get involved in your spat with jdb, thank you |
Posted at 02/10/2009 20:54 by boadicea Quote:"the_doctor - 26 Sep'09 - 11:27 - 4422 of 4422 - .... Unclear who Sultan are - do the Dixons have any stake there?" I don't know about the Dixons but I would guess there is a strong connection between Sultan and the recent chairmanship change at CBF. The Funding Announcement gave a reasonable explanation of the make-up and objectives of Sultan imho - "Sultan Scientific Limited operates internationally, investing in and building specialised companies capable of rapid commercialisation and value generation in the Medical and Environmental Technology sectors. "Sultan is a Private Investment Company under the Chairmanship of Sir John Banham with Managing Director, Dr Mike Hudson and management advisers and shareholders who often personally play key roles in the management of the companies in which they invest. Sultan is an active investor in a portfolio of high growth companies, selecting a single lead partner with whom to invest and work in key industry sectors." As regards the views of the Dixons on dilution etc, they may not have had much choice in the matter other than to dissent with possibly catastrophic results (although that is pure conjecture, of course.) Anyway, they are presumably part of the consenting 52% claimed in relation to the EGM. |
Posted at 22/9/2009 20:05 by rohkap Would like to know why the Dixons just didnt lend the £300k themselves rather than allow themselves to be diluted. Very generous terms offered to the new investors |
Posted at 12/5/2009 17:56 by jdb2005 Phoney - It seems that you know very little about vaccine manufacture and running a business. One day you are saying the order book looks good and then trying to imply they don't have the cash to pay their way. I would much rather rely on my research than yours. I repeat again £11m orders secured for 2009. 9 more months to increase their performance and to show investors they can run the business profitably. If they did not deliver products on time and to specification they would not be winning repeat orders. |
Posted at 08/4/2009 12:40 by imabastard Boring nonetheless .... you believe that other investors who have risked their funds (unlike you) are not fully aware of the risks .... you are deluded by a false premise assuming that you are the 'saviour' of the investing world waving a multitude of 'beware' banners and without your unending input, will be swept away with the tide of financial ignorance. Your biggest crime is the repetition with which you boringly emphasise the same old facets relating to the risk.I'm not in the slightest bit worried as you imply .... just bored to tears reading your painfully tedious posts. Yawn .... zzzz |
Posted at 08/4/2009 08:11 by hyper al Just not enough investors around during Easter holidays. |
Posted at 08/4/2009 00:37 by hyper al boadiceaYou never know, but at current share price we stand at just £1.7million, which is way short of what any bid will be. Maybe investors will take note, or maybe not, we will see. 10p certainly and 20p would be very nice, but I think we would need a battle to see that 20p. |
Posted at 07/4/2009 15:41 by the_doctor No, I dont hold CBF. Just watched it for a while and interested in how it does.Fwiw, I want success for the company. Just giving an objective view. The fact is that the company is on a knife edge. As such, I suggest not expecting too much. All said though, the main investors are probably long-termers and more relaxed. |
Posted at 07/4/2009 15:35 by the_doctor "Cobra had cash and cash equivalents of GBP0.3m as at 30 September 2008 and incurred a loss of GBP3.3m for the twelve months ended 30 September 2008." Any slippage with contracts and they're in trouble I spent years manufacturing biologics. Issues crop up! I'm not saying it will go down the pan, but these concerns may well result in investors accepting a lower price than you think |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
